Volume 4, Number 11, September 2016
View or download the full issue PDF (ENG)
Editor's Welcome PDF (ENG)
LEADING ARTICLE
Opportunities of new lipid-lowering therapy: proprotein convertase subtilisin/kexin type 9 inhibitors’ clinical efficacy and safety profile
Nevrez Koylan, Mamedov M.N.
3-7
REVIEW ARTICLES
Glycemic control in diabetes mellitus: review of international studies of glucose-lowering drugs cardiological safety
Akhmedova E.A., Dudinskaya E.N., Mardanov B.U., Abdalkina E.N., Kanorskii S.G.
7-12
Relationship between periodontal and cardiovascular diseases
Trukhan D.I., Trukhan L.Yu.
12-17
ORIGINAL ARTICLES
Estimation of atrial fibrillation risk development in patients with metabolic syndrome during atrial extrasystole registration
Olesin A.I., Litvinenko V.A., Shlapakova A.V., Konstantinova I.V.
17-27
Interrelation between statins and endothelial dysfunction marker in male and female patients with coronary atherosclerosis
Klimushina M.V., Gumanova N.G., Gorshkov A.Y., Gavrilova N.E., Metelskaya V.A.
27-31
Safety of chronic heart failure complex therapy: results of randomized crossover study BASTion
Averin E.E.
31-36
CONGRESS REPORT
News from the European Society of Cardiology Congress 2016
36-39
Russian National Congress of Cardiology: main results
